---
title: "Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q1 Revenue: USD 27.63 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238983571.md"
datetime: "2025-05-06T20:34:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238983571.md)
  - [en](https://longbridge.com/en/news/238983571.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238983571.md)
generator: "portal-rs"
---

# Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 10-Q: FY2025 Q1 Revenue: USD 27.63 M

Revenue: As of FY2025 Q1, the actual value is USD 27.63 M.

EPS: As of FY2025 Q1, the actual value is USD -0.04.

EBIT: As of FY2025 Q1, the actual value is USD 1.989 M.

### Healthcare IT Segment

-   **Net Revenue**: $24,643,000 for the three months ended March 31, 2025, compared to $22,721,000 for the same period in 2024.
-   **Operating Expenses**: Direct operating costs were $12,904,000, selling and marketing expenses were $1,124,000, general and administrative expenses were $2,112,000, research and development expenses were $1,235,000, and depreciation and amortization were $3,255,000 for the three months ended March 31, 2025.
-   **Operating Income**: $3,899,000 for the three months ended March 31, 2025, compared to $756,000 for the same period in 2024.

### Medical Practice Management Segment

-   **Net Revenue**: $2,989,000 for the three months ended March 31, 2025, compared to $3,241,000 for the same period in 2024.
-   **Operating Expenses**: Direct operating costs were $2,560,000, selling and marketing expenses were $7,000, general and administrative expenses were $642,000, and depreciation and amortization were $82,000 for the three months ended March 31, 2025.
-   **Operating Loss**: -$302,000 for the three months ended March 31, 2025, compared to $79,000 operating income for the same period in 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $5,113,000 for the three months ended March 31, 2025, compared to $4,066,000 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: -$1,510,000 for the three months ended March 31, 2025, compared to -$1,868,000 for the same period in 2024.
-   **Net Cash Used in Financing Activities**: -$1,932,000 for the three months ended March 31, 2025, compared to -$1,374,000 for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to continue enhancing its liquidity and financial position by managing expenses and growing revenue, with a focus on overall profitability.
-   **Non-Core Business**: The company completed an acquisition of an audiology-focused revenue cycle management company in April 2025, with consideration to be paid over the next 3.5 years based on collected revenue.

### Related Stocks

- [CCLDO.US](https://longbridge.com/en/quote/CCLDO.US.md)

## Related News & Research

- [Berkshire Hathaway Just Sold 3 Bank Stocks. Here’s Why Investors Should Take Notice](https://longbridge.com/en/news/297771081.md)
- [Next Phase Of AI–Elon Musk’s 1 Billion Robots](https://longbridge.com/en/news/297821554.md)
- [HPE Earnings Prediction Market Preview: Will Antonio Neri Say ‘Self Driving’ Again?](https://longbridge.com/en/news/297812809.md)
- [HPE follows in Dell's footsteps as it rides the AI server boom to a big earnings beat](https://longbridge.com/en/news/297824285.md)
- [Dan Ives Says M&A Is the ‘Missing Piece’ for Apple in AI Arms Race — New CEO John Ternus Could Finally Shake Up Tim Cook’s Playbook](https://longbridge.com/en/news/297774464.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**